Flyer

Journal of Neurology and Neuroscience

  • ISSN: 2171-6625
  • Journal h-index: 17
  • Journal CiteScore: 4.12
  • Journal Impact Factor: 3.20
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Scientific Journal Impact Factor (SJIF)
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Abstract

Evaluation of Wilson Disease With 18F-FDG PET/CT

Nudelman-Speckman A, Díaz-Meneses I, Valenzuela M and Kerik-Rottenberg N

Wilson disease is an autosomal-recessive disorder with copper accumulation and deposition in different organs. Disturbances in liver function and basal ganglia lead to hepatic and extrapyramidal motor symptoms. Age of onset ranges from 5 to 40 years of age. Wilson disease should be ruled out by measuring serum ceruloplasmin levels, and 24-hour urinary copper levels. We report a case of a 30 year-old female who had experienced progressive dystonia for a year. A decreased uptake of glucose metabolism using 18F-Fluoro-desoxyglucose-Positron-Emission- Tomography/Computed-Tomography (18F-FDG PET/CT) in the striatal area has been reported in the literature. With low levels of ceruloplasmin, elevation of aminotransferase activity and 24-hour urinary copper levels, associated with PET results using 18F FDG led to the diagnosis of Wilson disease. This study shows the feasibility of using in vivo imaging FDG PET/CT for identification of Wilson disease when there is a high clinical suspicion.